N/A Completed N=24 Randomized Double-blind Treatment

Pilot Study of Transcranial Stimulation (tDCS)to Relieve Neuropathic Pain in Cancer Patients

Postoperative Pain

Source: ClinicalTrials.gov NCT01948050 ↗

Enrolled (actual)

Serious AEs

8.3%

Results posted

Jul 2014

Primary outcomePrimary: Pain Intensity — 1.66; 1.60 Points on numerical rating scale

Summary

This is a pilot study designed to collect preliminary data on safety and efficacy of transcranial direct current stimulation (tDCS) to relieve pain in cancer patients who developed neuropathic pain in the affected area after a surgical intervention, radiation therapy, or chemotherapy to treat the disease.

Outcome Measures

Outcome	Result	p-value
PRIMARY Pain Intensity	1.66; 1.60	—

Eligibility Criteria

Adult male and female patients with cancer who developed neuropathic pain in the affected area secondary the surgical procedure, chemotherapy or radiation that meet the following Inclusion/Exclusion criteria:

Inclusion Criteria

Pain on the side of the lesion

Spontaneous pain with a score for "worst pain in the last 24 hours" >4 on a numeric scale 0-10
Must present the following symptoms and signs:
Continuous burning, shooting, or lancinating pain.
Presence of hyperesthesia
Presence of hyperalgesia (to pinprick) and/or allodynia (to light touch)

Exclusion Criteria

Uncontrolled hypertension, uncontrolled diabetes, uncontrolled cardiovascular disease
Pain/painful conditions unrelated to the cancer or related treatment
Pregnancy
History of seizures/epilepsy
Any implanted devices (e.g. a cardio stimulator, etc)
Active illegal drug/alcohol abuse
Unable to follow directions or complete tools in English

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT01948050). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.